Ledger.Open graph →
SEC Form D · Amendment · filed June 27, 2016

VERAX BIOMEDICAL INC

Offering
$24.5M
Sold
$12.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MARLBOROUGH, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Nancy A. Hornbaker · MARLBOROUGH, MAExecJames Lousararian · MARLBOROUGH, MAExec · DirectorJoe R. Sanders · MARLBOROUGH, MAExec · DirectorR. S. Mckenzie · MARLBOROUGH, MAExecPaul R. Ragusa · MARLBOROUGH, MAExecJoe Del Guercio · MARLBOROUGH, MADirectorYli R. Vallejo · MARLBOROUGH, MAExecMarc E. Goldberg · MARLBOROUGH, MADirectorJames E. Koziarz · MARLBOROUGH, MADirectorJonathan E. Bain · Grand Cayman, Cayman IslandsDirectorKevin Beyer · Philadelphia, PADirectorTonya J. Joly · New York, NYExec · DirectorDavid Welty · Philadelphia, PAExecJonathan Brook · London, United KingdomExecPeter Fitzpatrick · Rye Brook, NYDirectorDennis Glazer · Rye Brook, NYExec · DirectorGiles Hanson · Philadelphia, PAExecJon Groetzinger · New York, NYExec · DirectorJohn Locke · New York, NYExec · DirectorDavid Frankel · New York, NYDirectorRussell D'Souza · New York, NYExec · DirectorAfsaneh M. Beschloss · Washington, Washington, D.C.DirectorAnthony Olivieri · Bakersfield, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗